Clinical Trial Update: rAd-p53 Gene Therapy for Advanced Oral and Maxillofacial Malignant Tumors [Phase 4]

View source ↗

Summary

Clinical trial update for rAd-p53 gene therapy (Gendicine) evaluating advanced oral and maxillofacial malignant tumors in Phase 4; the current status is not pro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Oral Cancer

Drugs mentioned

• Gendicine (recombinant adenovirus p53 gene therapy)

Snippet

Sponsor: Shenzhen SiBiono GeneTech Co.,Ltd | Conditions: Advanced Oral and Maxillofacial Malignant Tumors | Phase 4 | Status: UNKNOWN